Androgenic alopecia is a common and major cause of progressive hair loss. Hair loss can be prevented by administrating concentrated growth factor concentrate (GFC) into the scalp where the person's own growth factors are effectively delivered deep within the layers of the scalp, promoting optimal results. This prospective study includes five patients with androgenic alopecia. Growth factor concentrates were injected subcutaneously into the scalp, and assessment was done before the procedure two and eight weeks after the first sitting. The treatment outcome was evaluated with macroscopic and trichoscopic microphotographs. The trichoscopic microphotographs provided further evidence of the notable improvement in hair density. Additionally, the hair pull test yielded negative results during the eight-week follow-up, confirming the positive outcomes of the GFC treatment. Patients were highly satisfied with the results: faster rate of hair growth, better quality of hair, and minimal side effects.
No takes yet. Share an insight, caveat, or question.
Bhargava et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: